当前期刊: JAMA Neurology Go to current issue    加入关注   
显示样式:        排序: 导出
我的关注
我的收藏
您暂时未登录!
登录
  • Error in Results
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-13

    The Original Investigation “Rate and Prognosis of Brain Ischemia in Patients With Lower-Risk Transient or Persistent Minor Neurologic Events,”1 published online September 23, 2019, contained an error in the Results section. The sentence “The final diagnosis (ischemic vs nonischemic cause) was unchanged after all investigations in 720 individuals (70.0%), revised from ischemic to nonischemic in 79 (7.7%), and revised from nonischemic to ischemic in 229 (22.3%)” should have said “The final diagnosis (ischemic vs nonischemic cause) was unchanged after all investigations in 720 individuals (70.0%), revised from nonischemic to ischemic in 79 (7.7%), and revised from ischemic to nonischemic in 229 (22.3%).” The article was corrected online.

    更新日期:2020-01-13
  • Assessment of the Validity of the 2HELPS2B Score for Inpatient Seizure Risk Prediction
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-13
    Aaron F. Struck; Mohammad Tabaeizadeh Fesharaki; Sarah E. Schmitt; Andres Rodriguez Ruiz; Christa B. Swisher; Thanujaa Subramaniam; Christian Hernandez; Safa Kaleem; Hiba A. Haider; Abbas Fodé Cissé; Monica B. Dhakar; Lawrence J. Hirsch; Eric S. Rosenthal; Sahar F. Zafar; Nicholas Gaspard; M. Brandon Westover
    更新日期:2020-01-13
  • Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-13
    Stephen Mullin; Laura Smith; Katherine Lee; Gayle D’Souza; Philip Woodgate; Josh Elflein; Jenny Hällqvist; Marco Toffoli; Adam Streeter; Joanne Hosking; Wendy E. Heywood; Rajeshree Khengar; Philip Campbell; Jason Hehir; Sarah Cable; Kevin Mills; Henrik Zetterberg; Patricia Limousin; Vincenzo Libri; Tom Foltynie; Anthony H. V. Schapira
    更新日期:2020-01-13
  • Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-13
    Stuart H. Isaacson; William Ondo; Carlayne E. Jackson; Richard M. Trosch; Eric Molho; Fernando Pagan; Mark Lew; Khashayar Dashtipour; Thomas Clinch; Alberto J. Espay
    更新日期:2020-01-13
  • Overcoming Neurophobia With the Help of Peruvian Talking Bears
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-13
    Brian Dewar; Gregory S. Day; Michel C. F. Shamy

    A juvenile Peruvian bear, of the species Tremarctos ornatus,1 presented to the emergency department after being found unconscious at 32 Windsor Gardens, London, England.2 The bear had been struck in the left posterior head region by a returning boomerang. On assessment, he demonstrated retrograde amnesia and language-related symptoms. When offered a bun, one of the patient’s favourite things to eat, he replied by asking, “What’s a bun?” Later, he demonstrated a pattern of repetitive behavior in which he forced air through pursed lips to generate a “phew” sound. Finally, the patient attempted to request a cup of tea, but was unable to produce the name of the desired item. These deficits persisted for 24 hours and then resolved completely.

    更新日期:2020-01-13
  • JAMA Neurology
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01

    Mission Statement: The mission of JAMA Neurology is to publish scientific information primarily important for those physicians caring for people with neurologic disorders but also for those interested in the structure and function of the normal and diseased nervous system. These specific aims are (1) to make timely publication of original research of the nervous system, (2) to record observations of single patients or groups of patients that will provide new information and insights, (3) to report more basic research that is pertinent to the understanding of disease, (4) to introduce topics of practice, ethics, teaching, and history that are useful, and (5) to provide a forum for discussion on topics that may be controversial in this field. This information will be published only after extensive peer review so that originality, clarity, and precision are ensured.

    更新日期:2020-01-13
  • Incomplete Author Name and Credentials in Byline
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01

    In the Original Investigation titled “Interrater Reliability of Experts in Identifying Interictal Epileptiform Discharges in Electroencephalograms,” published online October 21, 2019, in JAMA Neurology,1 an author’s middle initial and second degree were missing from the byline. The 10th author’s full name and credentials should have appeared as “Carlos F. Muniz, MD, MSc.” This article was corrected online.

    更新日期:2020-01-13
  • Left Atrial Enlargement Could Be Detected on Extended Computed Tomography Angiography Within Initial Stroke Assessment—Reply
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Jeff S. Healey; David J. Gladstone; Robert G. Hart

    In Reply We agree with Popkirov that left atrial volume is a better marker of incident atrial fibrillation than atrial diameter1; however, we did not have these data available at all of the sites participating in the New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial Versus ASA to Prevent Embolism in Embolic Stroke of Undetermined Source (NAVIGATE-ESUS) trial.2 Recently completed3 and ongoing4 studies will help determine if our observation has a clinical role and may provide additional data on left atrial size and function. Once all of these data are available, guidelines committees will likely make recommendations regarding the threshold values of left atrial size (if present) for which anticoagulation therapy appears beneficial for patients with embolic stroke of undetermined source. Such recommendations would have to consider how to extrapolate the clinical trial results, allowing for the many different methods for assessing left size. The clinical use of the proposed, nongated computed tomography protocol5 is interesting, but should await additional studies to define its sensitivity and specificity compared with echocardiography, particularly for detecting other potential cardioembolic causes of stroke, such as patent foramen ovale and left ventricular thrombus.6

    更新日期:2020-01-13
  • Left Atrial Enlargement Could Be Detected on Extended Computed Tomography Angiography Within Initial Stroke Assessment
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Stoyan Popkirov

    To the Editor In a secondary analysis of the New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial Versus ASA to Prevent Embolism in Embolic Stroke of Undetermined Source trial, Healey and colleagues1 determined that for patients with embolic stroke of undetermined source and left atrial enlargement rivaroxaban treatment was associated with a 74% reduction in recurrent stroke.1 The authors suggest that left atrial enlargement could become a new determinant in secondary stroke prevention.

    更新日期:2020-01-13
  • A Rare Form of Lipid Metabolic Encephalopathy
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Qian Qian; Du Cao; You-Dong Wei
    更新日期:2020-01-13
  • Pyogenic Brain Abscesses in a Patient With Digital Clubbing
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Vimal Kumar Paliwal; Sucharita Anand; Vivek Singh
    更新日期:2020-01-13
  • Developmental Venous Anomaly Inside a Glioblastoma
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Jose Danilo Bengzon Diestro; Julian Spears; Thomas R. Marotta
    更新日期:2020-01-13
  • Distinctive Magnetic Resonance Imaging Findings in IgLON5 Antibody Disease
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Han Chen; Jinze Wu; Sarosh R. Irani
    更新日期:2020-01-13
  • The Hazard of Negative (Not Neutral) Trials on Treatment of Acute Stroke: A Review
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Philip M. Bath; Jason P. Appleton; Timothy England
    更新日期:2020-01-13
  • Trends in Stroke Incidence Rates in Older US Adults: An Update From the Atherosclerosis Risk in Communities (ARIC) Cohort Study
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Silvia Koton; Yingying Sang; Andrea L. C. Schneider; Wayne D. Rosamond; Rebecca F. Gottesman; Josef Coresh
    更新日期:2020-01-13
  • Development of Expert-Level Automated Detection of Epileptiform Discharges During Electroencephalogram Interpretation
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Jin Jing; Haoqi Sun; Jennifer A. Kim; Aline Herlopian; Ioannis Karakis; Marcus Ng; Jonathan J. Halford; Douglas Maus; Fonda Chan; Marjan Dolatshahi; Carlos Muniz; Catherine Chu; Valeria Sacca; Jay Pathmanathan; Wendong Ge; Justin Dauwels; Alice Lam; Andrew J. Cole; Sydney S. Cash; M. Brandon Westover
    更新日期:2020-01-13
  • Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Sandra Vukusic; Fabien Rollot; Romain Casey; Julie Pique; Romain Marignier; Guillaume Mathey; Gilles Edan; David Brassat; Aurélie Ruet; Jérôme De Sèze; Elisabeth Maillart; Hélène Zéphir; Pierre Labauge; Nathalie Derache; Christine Lebrun-Frenay; Thibault Moreau; Sandrine Wiertlewski; Eric Berger; Xavier Moisset; Audrey Rico-Lamy; Bruno Stankoff; Caroline Bensa; Eric Thouvenot; Olivier Heinzlef; Abdullatif Al-Khedr; Bertrand Bourre; Mathieu Vaillant; Philippe Cabre; Alexis Montcuquet; Abir Wahab; Jean-Philippe Camdessanché; Ayman Tourbah; Anne-Marie Guennoc; Karolina Hankiewicz; Ivania Patry; Chantal Nifle; Nicolas Maubeuge; Céline Labeyrie; Patrick Vermersch; David-Axel Laplaud
    更新日期:2020-01-13
  • Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Patrick Waters; Giulia Fadda; Mark Woodhall; Julia O’Mahony; Robert A. Brown; Denise A. Castro; Giulia Longoni; Sarosh R. Irani; Bo Sun; E. Ann Yeh; Ruth Ann Marrie; Douglas L. Arnold; Brenda Banwell; Amit Bar-Or
    更新日期:2020-01-13
  • Developmental Trajectories of Infants With Multiplex Family Risk for Autism: A Baby Siblings Research Consortium Study
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Nicole M. McDonald; Damla Senturk; Aaron Scheffler; Jessica A. Brian; Leslie J. Carver; Tony Charman; Katarzyna Chawarska; Suzanne Curtin; Irva Hertz-Piccioto; Emily J. H. Jones; Ami Klin; Rebecca Landa; Daniel S. Messinger; Sally Ozonoff; Wendy L. Stone; Helen Tager-Flusberg; Sara Jane Webb; Gregory Young; Lonnie Zwaigenbaum; Shafali S. Jeste
    更新日期:2020-01-13
  • Association Between Post–Dural Puncture Headache After Neuraxial Anesthesia in Childbirth and Intracranial Subdural Hematoma
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Albert R. Moore; Paul M. Wieczorek; Jose C. A. Carvalho
    更新日期:2020-01-13
  • Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Kjetil Bjornevik; Kassandra L. Munger; Marianna Cortese; Christian Barro; Brian C. Healy; David W. Niebuhr; Ann I. Scher; Jens Kuhle; Alberto Ascherio
    更新日期:2020-01-13
  • Interrater Reliability of Experts in Identifying Interictal Epileptiform Discharges in Electroencephalograms
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Jin Jing; Aline Herlopian; Ioannis Karakis; Marcus Ng; Jonathan J. Halford; Alice Lam; Douglas Maus; Fonda Chan; Marjan Dolatshahi; Carlos F. Muniz; Catherine Chu; Valeria Sacca; Jay Pathmanathan; WenDong Ge; Haoqi Sun; Justin Dauwels; Andrew J. Cole; Daniel B. Hoch; Sydney S. Cash; M. Brandon Westover
    更新日期:2020-01-13
  • Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Kanjana S. Perera; Kelvin K. H. Ng; Sumiti Nayar; Luciana Catanese; Leanne Dyal; Mukul Sharma; Stuart J. Connolly; Salim Yusuf; Jackie Bosch; John W. Eikelboom; Robert G. Hart
    更新日期:2020-01-13
  • Association of Cavum Septum Pellucidum and Cavum Vergae With Cognition, Mood, and Brain Volumes in Professional Fighters
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Jonathan K. Lee; Jenny Wu; Jennifer Bullen; Sarah Banks; Charles Bernick; Michael T. Modic; Paul Ruggieri; Lauren Bennett; Stephen E. Jones
    更新日期:2020-01-13
  • Feasibility, Safety, and Outcome of Endovascular Recanalization in Childhood Stroke: The Save ChildS Study
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Peter B. Sporns; Ronald Sträter; Jens Minnerup; Heinz Wiendl; Uta Hanning; René Chapot; Hans Henkes; Elina Henkes; Astrid Grams; Franziska Dorn; Omid Nikoubashman; Martin Wiesmann; Georg Bier; Anushe Weber; Gabriel Broocks; Jens Fiehler; Alex Brehm; Marios Psychogios; Daniel Kaiser; Umut Yilmaz; Andrea Morotti; Wolfgang Marik; Richard Nolz; Ulf Jensen-Kondering; Bernd Schmitz; Stefan Schob; Oliver Beuing; Friedrich Götz; Johannes Trenkler; Bernd Turowski; Markus Möhlenbruch; Christina Wendl; Peter Schramm; Patricia Musolino; Sarah Lee; Marc Schlamann; Alexander Radbruch; Nicole Rübsamen; André Karch; Walter Heindel; Moritz Wildgruber; André Kemmling
    更新日期:2020-01-13
  • Medical Management vs Mechanical Thrombectomy for Mild Strokes: An International Multicenter Study and Systematic Review and Meta-analysis
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Nitin Goyal; Georgios Tsivgoulis; Konark Malhotra; Muhammad F. Ishfaq; Abhi Pandhi; Michael T. Frohler; Alejandro M. Spiotta; Mohammad Anadani; Marios Psychogios; Volker Maus; Adnan Siddiqui; Muhammad Waqas; Peter D. Schellinger; Marcel Groen; Christos Krogias; Daniel Richter; Maher Saqqur; Pablo Garcia-Bermejo; Maxim Mokin; Ronen Leker; Jose E. Cohen; Aristeidis H. Katsanos; Georgios Magoufis; Klearchos Psychogios; Vasileios Lioutas; Meg VanNostrand; Vijay K. Sharma; Maurizio Paciaroni; Alexandros Rentzos; Hazem Shoirah; J. Mocco; Christopher Nickele; Violiza Inoa; Daniel Hoit; Lucas Elijovich; Andrei V. Alexandrov; Adam S. Arthur
    更新日期:2020-01-13
  • Endovascular Therapy for Childhood Stroke—Working Together to Reach Prime Time
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Christine Fox; Nomazulu Dlamini

    The standard of care for stroke treatment in adults changed rapidly in 2015 after results from 5 major clinical trials each showed efficacy of endovascular treatment of anterior circulation large-vessel occlusion within 6 hours of stroke onset.1-5 The positive results of these studies have since raised questions about whether endovascular therapy should be used for children who present with stroke due to large-vessel occlusion and, other than age, fit adult criteria for thrombectomy. Compared with the occurrence in adults, ischemic stroke in children is uncommon, but remains important to address because the resulting disability from a stroke in a child is costly at individual and societal levels.6 While it would be ideal to conduct a randomized trial to test efficacy of endovascular treatment in children, this type of study would be challenging owing to slow participant accrual. Few adult stroke trials have included children, and, to our knowledge, there have been no large, randomized efficacy trials of acute stroke treatment aimed specifically for children. The lack of clinical trials in pediatric stroke poses challenges to clinicians who are left to extrapolate best practices from research conducted in adults. On the strength of adult studies, in 2015, the American Heart Association/American Stroke Association guidelines suggested that mechanical thrombectomy with stent retrievers was reasonable to consider for some patients younger than 18 years with large-vessel occlusion.7

    更新日期:2020-01-13
  • The Patient I Didn’t Like
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Marinos G. Sotiropoulos

    I didn’t like her when I first met her, and I definitely didn’t like her family. I was in my final year in medical school during my advanced medicine clerkship. I was full of excitement. As soon as I had walked in after winter holidays, the resident fellow had grabbed me and said, “There’s a lot for you to do. We have a new patient, a 30-year-old woman who was transferred here from a smaller hospital. She has a rare myopathy.” She didn’t know much about her disease, her treatments, anything. All our questions were answered by her mother, an extremely short woman whom I found controlling. She claimed (the mother was the only one who spoke) that she was fully satisfied by the physicians but had complaints about everything else; if she wasn’t asking for a change of room or yelling at the cleaning personnel for not meeting her cleaning standards, she was disturbing the nurses or complaining about something else to a stranger in the corridor.

    更新日期:2020-01-13
  • Are Daylight Saving Time Changes Bad for the Brain?
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Beth A. Malow; Olivia J. Veatch; Kanika Bagai
    更新日期:2020-01-13
  • Mendelian Randomization—A Journey From Obscurity to Center Stage With a Few Potholes Along the Way
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01
    Sara Bandres-Ciga; Alastair J. Noyce; Bryan J. Traynor
    更新日期:2020-01-13
  • Highlights
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-01

    Although mechanical thrombectomy (MT) is the standard of care for anterior circulation acute large-vessel occlusion (LVO), it is not known whether MT benefits patients with National Institutes of Health Stroke Scale scores less than 6. Goyal and colleagues evaluated 364 patients with mild deficits and acute LVO treated with MT or best medical management in a retrospective pooled multicenter study over a 5-year period. The patients treated with MT experienced higher odds of asymptomatic intracerebral hemorrhage (ICH) and lower rates of 3-month functional independence compared with patients treated with best medical management. In a meta-analysis that included 843 patients from 4 studies, MT was associated with higher odds of symptomatic ICH, but no other differences, suggesting a clinical trial in this patient population is warranted. Randomized clinical trials show efficacy of endovascular recanalization for stroke treatment in adults, but it is not clear whether these results can be applied to pediatric patients with stroke with large-vessel occlusion. Sporns and coauthors found that endovascular recanalization appeared to be safe with positive interventional and neurologic outcomes in this pediatric population. The study findings showed that the rate of recanalization, complications, and neurologic outcomes were comparable with those in adult trials and therefore support endovascular recanalization in children with acute, large-vessel occlusion. Editorial perspective is provided by Fox and Dlamini. Editorial

    更新日期:2020-01-13
  • Missing Funding Information in Funding/Support
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-06

    In the Original Investigation titled “Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease,”1 published online October 28, 2019, the following funding information was missing from Funding/Support: “This work was supported by funding from the National Institute on Aging Mayo Clinic Alzheimer’s Disease Research Center (P50 AG016574 and P30 AG062677).” The article was corrected online.

    更新日期:2020-01-06
  • Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-06
    William G. Mantyh; Salvatore Spina; Alex Lee; Leonardo Iaccarino; David Soleimani-Meigooni; Elena Tsoy; Taylor J. Mellinger; Harli Grant; Lawren Vandevrede; Renaud La Joie; Orit Lesman-Segev; Stephanie Gaus; Katherine L. Possin; Lea T. Grinberg; Bruce L. Miller; William W. Seeley; Gil D. Rabinovici
    更新日期:2020-01-06
  • Association of Time Since Injury to the First Clinic Visit With Recovery Following Concussion
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-06
    Anthony P. Kontos; Kendra Jorgensen-Wagers; Alicia M. Trbovich; Nathan Ernst; Kouros Emami; Brandon Gillie; Jonathan French; Cyndi Holland; R. J. Elbin; Michael W. Collins
    更新日期:2020-01-06
  • Association of Neighborhood-Level Disadvantage With Cerebral and Hippocampal Volume
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-06
    Jack F. V. Hunt; William Buckingham; Alice J. Kim; Jennifer Oh; Nicholas M. Vogt; Erin M. Jonaitis; Tenah K. Hunt; Megan Zuelsdorff; Ryan Powell; Derek Norton; Robert A. Rissman; Sanjay Asthana; Ozioma C. Okonkwo; Sterling C. Johnson; Amy J. H. Kind; Barbara B. Bendlin
    更新日期:2020-01-06
  • Best of JAMA Neurology 2019: Research That Drives Practice
    JAMA Neurol. (IF 12.321) Pub Date : 2020-01-06
    Hooman Kamel; Dena B. Dubal

    Studies published in JAMA Neurology in 2019 featured a breadth of diverse and highly influential investigations. Here, we highlight a few of many exciting studies from the past year that illustrate major strides in neurology across fields from a lens of varied experimental approaches. Randomized clinical trials (RCTs) play a vital role in health care decision-making, so we have been particularly pleased by the increasing number of high-profile RCTs published in JAMA Neurology. Several of these in the fields of stroke, pain, and behavioral neurology promise to directly inform practice and policy—and thus quickly affect care delivery.

    更新日期:2020-01-06
  • The Term Mild in Mild Traumatic Surgery and the Representation of Outcomes—Reply
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-30
    Lindsay D. Nelson; Harvey S. Levin; Michael A. McCrea

    In Reply We recently reported that many patients who presented to level 1 trauma centers after mild traumatic brain injury (mTBI) continued to report injury-related functional limitations at 1 year postinjury.1 Our findings are from the TRACK-TBI study, one of the most comprehensive prospective investigations of civilian TBI to date. A recent Letter to the Editor suggested that our findings veer from seminal work by several of our coauthors that was published 20 or more years ago. We contend that our results reflect major advances in brain injury science over the past 2 decades, including our understanding of mTBI. Levin et al2 and Dikmen et al3 focused on cognitive outcomes, not functional limitations, and analyzed narrower and broader TBI populations, respectively. Accordingly, they were not directly informative to cite in the present study. Our findings should also not be considered interchangeable with the research from McCrea et al4 on athletes with sport-related concussion. Factors, such as preinjury physical conditioning5 and TBI severity,3 are associated with recovery after mTBI; consequently, we should not assume that the rapid recovery experienced by most healthy athletes with sport-related concussion is generalizable to expected recovery in the broader neurotrauma population.

    更新日期:2019-12-30
  • The Term Mild in Mild Traumatic Surgery and the Representation of Outcomes
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-30
    Jim Andrikopoulos

    To the Editor Nelson et al1 state that the term mild in mild traumatic brain injury misrepresents the burden of traumatic brain injury. Seminal prospective controlled studies by 3 of Nelson’s own coauthors, who are neuropsychologists, that date back to the 1980s contradict the findings of this article.1 To my knowledge, Levin et al2 were the first to conclusively show that a single uncomplicated mild head injury produces no permanent neurobehavioral impairment. A Glasgow Coma Scale score of 13 to 15 and a coma not to exceed 20 minutes was introduced earlier as a definition of mild head injury.3 Levin et al2 added normal imaging as the third defining feature to separate those with complicated mild head injury, namely acute imaging abnormalities. An earlier study3 that included patients with mild complicated injury showed cognitive and functional impairment. Dikmen et al4 published the second important article. One year post–head injury, patients who took up to an hour to follow commands did not differ cognitively from the controls. Curiously, neither of these 2 articles are cited by Nelson et al.1 The benign outcome of mild head injury seen in the civilian literature was established by McCrea et al5 in the best-characterized sports concussion sample published at that time. The cognitive effects of concussion resolve in 7 days.5

    更新日期:2019-12-30
  • Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS)
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-30
    Christina N. Fournier; Richard Bedlack; Colin Quinn; James Russell; Diane Beckwith; Kathleen H. Kaminski; William Tyor; Vicki Hertzberg; Virginia James; Meraida Polak; Jonathan D. Glass
    更新日期:2019-12-30
  • Prognostic Value of Spreading Depolarizations in Patients With Severe Traumatic Brain Injury
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-30
    Jed A. Hartings; Norberto Andaluz; M. Ross Bullock; Jason M. Hinzman; Bruce Mathern; Clemens Pahl; Ava Puccio; Lori A. Shutter; Anthony J. Strong; Achala Vagal; J. Adam Wilson; Jens P. Dreier; Laura B. Ngwenya; Brandon Foreman; Laura Pahren; Hester Lingsma; David O. Okonkwo
    更新日期:2019-12-30
  • Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-30
    Angela K. Birnbaum; Kimford J. Meador; Ashwin Karanam; Carrie Brown; Ryan C. May; Elizabeth E. Gerard; Evan R. Gedzelman; Patricia E. Penovich; Laura A. Kalayjian; Jennifer Cavitt; Alison M. Pack; John W. Miller; Zachary N. Stowe; Page B. Pennell
    更新日期:2019-12-30
  • Error in Results
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-20

    The Research Letter “Perception of Dementia Risk and Preventive Actions Among US Adults Aged 50 to 64 Years,”1 published online November 15, 2019, contained an error in the Results section. The phrase “Respondents who rated their physical or mental health as fair or poor reported a higher likelihood of developing dementia” should have said “mental health” only, omitting the mention of physical health. The article was corrected online.

    更新日期:2019-12-21
  • CRMP5-IgG–Associated Paraneoplastic Myelopathy With PD-L1 Inhibitor Therapy
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-20
    Amy Kunchok; Anastasia Zekeridou; Sean Pittock
    更新日期:2019-12-21
  • Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-20
    Andy J. Liu; Adam M. Staffaroni; Julio C. Rojas-Martinez; Nicholas T. Olney; Carolina Alquezar-Burillo; Peter A. Ljubenkov; Renaud La Joie; Jamie C. Fong; Joanne Taylor; Anna Karydas; Eliana Marisa Ramos; Giovanni Coppola; Adam L. Boxer; Gil D. Rabinovici; Bruce L. Miller; Aimee W. Kao
    更新日期:2019-12-21
  • Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-20
    Joseph Therriault; Andrea L. Benedet; Tharick A. Pascoal; Sulantha Mathotaarachchi; Mira Chamoun; Melissa Savard; Emilie Thomas; Min Su Kang; Firoza Lussier; Cecile Tissot; Marlee Parsons; Muhammad Naveed Iqbal Qureshi; Paolo Vitali; Gassan Massarweh; Jean-Paul Soucy; Soham Rej; Paramita Saha-Chaudhuri; Serge Gauthier; Pedro Rosa-Neto
    更新日期:2019-12-21
  • Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-20
    Edwin Jabbari; Negin Holland; Viorica Chelban; P. Simon Jones; Ruth Lamb; Charlotte Rawlinson; Tong Guo; Alyssa A. Costantini; Manuela M. X. Tan; Amanda J. Heslegrave; Federico Roncaroli; Johannes C. Klein; Olaf Ansorge; Kieren S. J. Allinson; Zane Jaunmuktane; Janice L. Holton; Tamas Revesz; Thomas T. Warner; Andrew J. Lees; Henrik Zetterberg; Lucy L. Russell; Martina Bocchetta; Jonathan D. Rohrer; Nigel M. Williams; Donald G. Grosset; David J. Burn; Nicola Pavese; Alexander Gerhard; Christopher Kobylecki; P. Nigel Leigh; Alistair Church; Michele T. M. Hu; John Woodside; Henry Houlden; James B. Rowe; Huw R. Morris
    更新日期:2019-12-21
  • Association of Intracranial Atherosclerotic Disease With Brain β-Amyloid Deposition: Secondary Analysis of the ARIC Study
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-20
    Rebecca F. Gottesman; Thomas H. Mosley; David S. Knopman; Qing Hao; Dean Wong; Lynne E. Wagenknecht; Timothy M. Hughes; Ye Qiao; Jennifer Dearborn; Bruce A. Wasserman
    更新日期:2019-12-21
  • Association Between Cigarette Smoking and Multiple Sclerosis: A Review
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-16
    Mattia Rosso; Tanuja Chitnis
    更新日期:2019-12-17
  • Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-16
    Fernando. L. Pagan; Michaeline L. Hebron; Barbara Wilmarth; Yasar Torres-Yaghi; Abigail Lawler; Elizabeth E. Mundel; Nadia Yusuf; Nathan J. Starr; Muhammad Anjum; Joy Arellano; Helen H. Howard; Wangke Shi; Sanjana Mulki; Tarick Kurd-Misto; Sara Matar; Xiaoguang Liu; Jaeil Ahn; Charbel Moussa
    更新日期:2019-12-17
  • The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-16
    Alberto J. Espay; Robert A. Hauser; Melissa J. Armstrong

    Nilotinib hydrochloride, an Abelson tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia, has been in the neurology news since the results of the open-label, phase 1 study in a small group of patients with advanced Parkinson disease (PD) and dementia with Lewy bodies was reported at the Society for Neuroscience in Chicago in October 2015. The extensive media coverage that followed, supported by videos of nilotinib-treated participants getting up and walking from their wheelchairs, suggested that disease modification in PD was within reach with this drug. The corresponding publication documented that, at 150 and 300 mg/d, doses lower than required for treating leukemia, nilotinib was detectable in the cerebrospinal fluid (CSF), increased CSF homovanillic acid levels, seemed to engage the target Abelson, and was relatively safe and well tolerated at 24 weeks.1 Although the authors emphasized that “motor and cognitive outcomes suggest a possible beneficial effect on clinical outcomes,”1(p503) the accompanying editorial noted that, owing to the small sample size and lack of a control group, it was impossible to rule out a placebo effect.2

    更新日期:2019-12-17
  • Freezing of Gait and its Levodopa Paradox
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-16
    Jorik Nonnekes; Matthieu Bereau; Bastiaan R. Bloem
    更新日期:2019-12-17
  • Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-09
    Christina L. Szperka, Juliana H. VanderPluym, Christopher B. Oakley
    更新日期:2019-12-11
  • Association Between Breastfeeding and Postpartum Multiple Sclerosis Relapses: A Systematic Review and Meta-analysis
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-09
    Kristen M. Krysko, Alice Rutatangwa, Jennifer Graves, Ann Lazar, Emmanuelle Waubant
    更新日期:2019-12-11
  • Safety and Efficacy of Intra-arterial Urokinase After Failed, Unsuccessful, or Incomplete Mechanical Thrombectomy in Anterior Circulation Large-Vessel Occlusion Stroke
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-09
    Johannes Kaesmacher, Sebastian Bellwald, Tomas Dobrocky, Thomas R. Meinel, Eike I. Piechowiak, Martina Goeldlin, Christoph C. Kurmann, Mirjam R. Heldner, Simon Jung, Pasquale Mordasini, Marcel Arnold, Pascal J. Mosimann, Gerhard Schroth, Heinrich P. Mattle, Jan Gralla, Urs Fischer
    更新日期:2019-12-11
  • Potential of Intra-arterial Urokinase After Incomplete Mechanical Thrombectomy: Looking Back, Moving Forward
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-09
    Victor Lopez-Rivera, Sunil A. Sheth

    Complete and rapid revascularization can dramatically reduce disability after large-vessel occlusion (LVO) acute ischemic stroke (AIS).1 With modern mechanical thrombectomy (MT), we now have a safe and effective method to recanalize occluded cerebral vessels, and in this issue of JAMA Neurology, Kaesmacher et al2 move the field 1 step closer to achieving the goal of complete revascularization. Cohort studies have demonstrated that even among patients who achieve substantial reperfusion, defined as a Thrombolysis in Cerebral Infarction grade of 2b or greater, those who achieve the highest grades of reperfusion have quantifiably improved outcomes, but only a minority are able to achieve these highest grades.3 As such, one of the primary targets for improvement in MT is finding reliable means of achieving near-perfect reperfusion.

    更新日期:2019-12-11
  • Active Immunotherapy to Prevent Alzheimer Disease—A DNA Amyloid β 1-42 Trimer Vaccine
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-09
    Roger N. Rosenberg, Doris Lambracht-Washington

    Immunotherapy directed to reduce amyloid levels in the brains of patients with Alzheimer disease (AD) and provide clinical benefit has not definitely been successful using either passive immunizations with preformed antiamyloid (anti-Aβ42 as the toxic processed form of amyloid β protein), monoclonal antibodies (moabs), or active immunization with amyloid peptides. A recent press release by Biogen1 has indicated that their moab aducanumab has shown clinical benefit after reanalysis of larger data panels of a phase 3 clinical trial that ended in March 2019. This reanalysis has not been published or reproduced, but it is potentially an important finding and supportive of immunotherapy for AD. Thus, antiamyloid immunotherapy still holds promise for clinical benefit, as amyloid (Aβ) accumulation in the brain can be detected decades before the onset of symptoms and amyloid accumulation is a trigger for many downstream pathologies, such as loss of neuronal plasticity, tau hyperphosphorylation, and frank neuronal death. Targeting more than one pathology with a single therapy, as we have shown for the DNA Aβ42 trimer vaccine, might be the path forward in finding an option for AD prevention or delay of disease progression.2

    更新日期:2019-12-11
  • JAMA Neurology
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-01

    Mission Statement: The mission of JAMA Neurology is to publish scientific information primarily important for those physicians caring for people with neurologic disorders but also for those interested in the structure and function of the normal and diseased nervous system. These specific aims are (1) to make timely publication of original research of the nervous system, (2) to record observations of single patients or groups of patients that will provide new information and insights, (3) to report more basic research that is pertinent to the understanding of disease, (4) to introduce topics of practice, ethics, teaching, and history that are useful, and (5) to provide a forum for discussion on topics that may be controversial in this field. This information will be published only after extensive peer review so that originality, clarity, and precision are ensured.

    更新日期:2019-12-11
  • Errors in Table and Supplemental Figure
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-01

    In the Original Investigation entitled “Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo,”1 there were errors in the article’s Table and in eFigure 2 of the Supplement. The cell for “≥4 Rims” and “Sex, Female, No. (%)” was left empty, and it should be “28 (67).” This article was corrected online.

    更新日期:2019-12-11
  • Error in Affiliation
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-01

    The Review “Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review,”1 published in October 2019, had an error in an affiliation. Dr Nolano’s affiliation was reported as “Skin Biopsy Laboratory, Department of Neurology, IRCCS, SpA SB, Telese Terme, Italy,” omitting another institutional name that should have come after “IRCCS.” The name, “Istituti Clinici Scientifici Maugeri,” has been added to correct the error.

    更新日期:2019-12-11
  • Incorrect Affiliation
    JAMA Neurol. (IF 12.321) Pub Date : 2019-12-01

    In the Clinical Challenge titled “A Case of Muscle Twitching With Psoriasis,”1 published online July 15, 2019, Dr Qin’s affiliation was listed as the Department of Medicine at the University of Massachusetts Medical School, but the correct affiliation is the Department of Neurology. This article was corrected online.

    更新日期:2019-12-11
Contents have been reproduced by permission of the publishers.
导出
全部期刊列表>>
2020新春特辑
限时免费阅读临床医学内容
ACS材料视界
科学报告最新纳米科学与技术研究
清华大学化学系段昊泓
自然科研论文编辑服务
中国科学院大学楚甲祥
上海纽约大学William Glover
中国科学院化学研究所
课题组网站
X-MOL
北京大学分子工程苏南研究院
华东师范大学分子机器及功能材料
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug